Pseudo-acylceramides with different acyl properties were investigated for their capacity to restore diminished barrier function in essential fatty acid-deficient rats. Daily topical applications of synthetic pseudo-acylceramides containing ester-linked linoleic acid caused a dose-dependent, significant reduction of transepidermal water loss (TEVL). Both other pseudo-acylceramides with ester-linked oleic acid or saturated alkyl chains and ordinary ceramides exhibited a poor effect on recovery of TEWL. Furthermore, pseudoceramide containing ether-linked linoleic acid, which is biologically inactive in terms of degradation by hydrolytic enzymes, also induced a significant and similar increase in the barrier function. This restoration of barrier function by pseudo-acylceramides with linoleic acid was accompanied by suppressed DNA synthesis in the EFAD rat epidermis. In UVB-irradiated guinea pig skin, topical applications of the pseudo-acylceramides with linoleic acid immediately after the exposure significantly reduced epidermal hyperplasia, secondary to markedly diminished barrier disruption, whereas linoleic acid itself did not. A comparison of both the anti-hyperplasia and the barrier recovery effects in the series of pseudo-ceramide derivatives examined revealed that the suppressive effect on the induced epidermal hyperplasia was paralleled by the recovery of the barrier defect in EFAD rats. These findings directly suggest that acylceramide with an ester-linked linoleic acid has an essential role in the epidermal permeability barrier. (J. Clin. Invest. 1994. 94:89-96.) Key words: permeability barrier -pseudo-acylceramide * epidermal hyperplasia * linoleic acid
Introduction
Sphingolipids are an important constituent of the permeability barrier of the stratum corneum (1) . However, the predominant species of ceramides associated with this barrier function remain to be clarified. Recent studies of essential fatty acid deficiency (EFAD)' in animals have shown that acylceramide with linoleic acid in an ester linkage is replaced by acylceramide with oleic acid in parallel with the progression of barrier defects that occur when a linoleic acid-depleted diet is given to animals (2, 3) , suggesting the importance of the former in barrier function. However, there is no direct evidence to show whether such acylceramides are involved in barrier functions. During studies on the water-retaining mechanism of the stratum corneum (4-7), we established pseudo-ceramide structures that function in a manner similar to that of naturally occurring ceramides (8, 9) . In an attempt to directly study the role of acylceramide with linoleic acid in controlling barrier function, we synthesized pseudo-acylceramides with different acyl properties and examined their potential in recovering diminished barrier function in EFAD rats. Based upon recent evidence (10, 11) of the relevance of perturbed barrier function to epidermal proliferation, we also assessed the effects of topical applications of these agents on the epidermal hyperplasia that occurs in barrier-interrupted guinea pig skin.
Methods
EFAD animals. Wistar rats (male, 4-wk old) received a diet consisting of casein, sucrose, choline, a mixture of salts, the fat-soluble vitamins, A, D, and E, and the water-soluble B vitamins, to which 5% corn oil and inositol (1 mg/g) was added. The deficient group were fed identical quantities of all of the above for 8-10 wk, except that equal parts of hydrogenated coconut oil (C8:0, 6.8; C10i:, 5.7; C12:0, 45.1; C14:0, 19.1; C16:0, 10.3; C18:0, 11.8; C18:2, 0.3; C20:0, 0.1 weight %) were substituted for corn oil.
Materials. Pseudo-ceramide derivatives were synthesized essentially according to the method described previously (9) . The chemical structures of the synthesized compounds and their assigned compound numbers are shown in Fig. 1 Petri dishes in MCDB-153 medium, supplemented with 200 U/mi penicillin, 100 pg/ml streptomycin, 0.63 jsg/ml fungizone (Flow Laboratories, Inc., McLean, VA), 70 j.g/mI bovine pituitary extract (PelFreeze Biologicals, Rogers, AR), 1 ng/ml epidermal growth factor (Sigma Chemical Co., St. Louis, MO), 50 /uM hydrocortisone (GIBCO BRL, Gaithersburg, MD), 0.1 mM ethanolamine, and 0.1 mM phosphoethanolamine (Sigma Chemical Co.).
DNA synthesis. DNA synthesis in the epidermis was evaluated by measuring the incorporation of methyl-['H] thymidine into tissue in an skin organ culture, as described elsewhere (12). 1 liCi/ml of methyl-
[3H]thymidine was incubated for 4 h in the skin organ culture, which was biopsied immediately after the topical application of the synthetic compounds ceased. Organ cultured skin was separated by dispase digestion into epidermis and dermis. The radioactivity incorporated into the epidermal sheet (5 x 5 mm2) after 5% TCA treatment was then measured using a liquid scintillation counter. The DNA synthesis of human keratinocytes was measured by determining methyl-[3H]thymidine incorporation in cultured cells. In proliferative stages conditioned by the above described medium, the cells were pulse-labeled with 1 methyl-[3H]thymidine (25 pCi/mmol) for the last 4 h of a 24-h incubation and the incorporated labeled thymidine was determined using a liquid scintillation counter, after the cells were washed twice with cold Hank's balanced solution, followed by 5% TCA treatment and solubilization with 1 N NaOH.
Assay of degradative properties. 20 kl of [ 14C] BRS-001 (10' dpm) in chloroform was applied to the EFAD rat shaved skin using a penetration chamber. After 24 h, the skin was washed with chloroform for a few seconds, separated, and stripped with cyanoacrylate resin and scotch tape to obtain whole layers of the stratum corneum. Lipids in the stripped stratum corneum were extracted with 20 ml of chloroform. The extracts were solubilized in 100 Ml chloroform and analyzed by HP-TLC. HP-TLC plates were developed with chloroform/methanol (10:1) to resolve pseudo-acylceramide and linoleic acid. After development, the chromatograms were air-dried and scanned for radioactivity (System 2001 imaging scanner; Biosan Inc., Wash. DC). The remnant, which consists of epidermis and dermis, was also extracted with chloroform for HP-TLC analysis. In a separate experiment, the remnant was solubilized in 2 N NaOH and neutralized by 2 N HCl for scintillation counting.
Epidermal hyperplasia. The effects of the agents on epidermal hyperplasia were evaluated by measuring the thickness of the epidermis, excluding the stratum corneum, in guinea pig ear skin. The synthetic compounds, emulsified at a concentration of 10% in squalane, were applied twice a day for 1 wk to guinea pig ear skin immediately after the skin had been irradiated at 2 MED dose of UVB light (Toshiba FL20E lamp) with an intensity of 0.6 mW/cm2 at 305 nm (1 MED = 0.29 J/cm2) or immediately after it had been stripped 15 times with scotch tape. Thereafter, the skin was biopsied and stained with hematoxylin and eosin to measure the epidermal thickness. The thickness of the Malpighian layer of the epidermis, namely the distance from the dermalepidermal interface to the junction between the granular and keratin layers, was measured microscopically in 200 sites in the section using a calibrated eyepiece oriented perpendicular to the dermal-epidermal interface.
Results
Effects ofpseudo-acylceramides on impaired barrier function. concentration of 10%. Topical application of pseudo-acylceramide with ester-linked linoleic acid (BRS-001) produced a marked reduction in TEWL after 2 wk of treatment, whereas no significant reduction was associated with other pseudoceramides (BRS-000, 004), including those with unsaturated alkyl chains (BRS-005, 006, 007, and 008) or with long alkyl chains (BRS-002). To rule out the possibility that the applied pseudoacylceramides were hydrolyzed by epidermal hydrolytic enzymes to yield linoleic acid, which can evoke barrier recovery, we studied the barrier recovery effects of a pseudo-ceramide (BRS-010) in which the ester linkage was replaced by an ether bond; this agent contained ether-linked linoleic acid. As seen in Fig. 2 B, BRS-010 also significantly corrected barrier disruption in the EFAD rat. Effects ofpseudo-acylceramides on epidermal DNA synthesis of EFAD rat. As shown in Fig. 7 , in accordance with the observed recovery effect on barrier function, a 2-wk application of pseudo-acylceramide with ester-linked linoleic acid (BRS-001) and ether-linked pseudo-ceramide with linoleic acid (BRS-010) produced a significant reduction in DNA synthesis in the EFAD rat epidermis when measured in organ cultured skin, as compared with vehicle-treated controls, whereas a pseudo-acylceramide with oleic acid (BRS-013), and a saturated, branched alkyl chain pseudoacyceramide (BRS-014) and an ordinary pseudo-ceramide with long alkyl chains (BRS-011 ) had no significant inhibitory effect on DNA synthesis.
Effects of pseudo-acylceramides on UVB exposed or stripped skin ofguinea pig. Consistent with the effect on EFAD rat skin, when 10% BRS-001 was applied daily for 1 wk immediately after exposing the ear skin of guinea pig to UVB irradiation at a dose of 2 MED, the induced disruption of barrier function as revealed by the increased TEWL value was signifi-40C-labeled BRS-O01 ND, not detectable; the total radio-activity of the remnant (epidermis + dermis) was negligible. The purity of BRS-001 and the linoleic acid release was assessed by HPTLC of the chloroform extract from the stratum corneum or the remnant (epidermis+dermis) of skin to which BRS-001 was applied for 24 h. The radioactivity in the remnant was also measured using a scintilation counter. The total radioactivity applied to HPTLC was -5,000 and 4,800 dpm for the original sample before, and the stratum corneum extract after application, respectively.
cantly diminished (Fig. 8) . To examine the inhibitory effect of BRS-001 and BRS-010 on the induced epidermal hyperplasia, BRS derivatives were applied daily to UVB-irradiated or tapestripped guinea pig skin; after 1 wk, the thickness of the epidermis was measured (Fig. 9) . BRS-001 and BRS-010 produced a significant suppression in epidermal thickness as compared with vehicle-treated controls, whereas linoleic acid itself and ordinary pseudo-ceramides (BRS-000 and 011) did not (Fig.  10, A and B). It should be noted that there was no inflammatory reaction due to the applied materials including linoleic acid, during the experimental period. Relationship between anti-hyperplasia and barrier recovery effect. Comparison of anti-hyperplasia and barrier recovery effects of this series of pseudo-ceramide derivatives (Fig. 11) revealed that the suppressive effect on the UVB-induced epiderunlabeled standard Figure 6 . High Performance TLC of the extracts from stratum corneum of EFAD rat skin at 24 h after the application of '4C-BRS-001. 20 mal permeability barrier (13, 14 minor component of stratum corneum lipids. Since there is no technique available for selectively extracting individual lipid components from the stratum corneum in vivo and since there is a limited availability of natural ceramides for experiments, little is known about their significance in this proposed barrier function. Thus, we used synthetic pseudo-acylceramides with various alkyl chain properties, including those with ester-linked linoleic acid, to directly evaluate their capacity to recover barrier function in EFAD rat skin. The present study indicated that not only pseudo-acylceramide with linoleic acid in an ester linkage, but also a pseudoceramide containing ether-linked linoleic acid produced a significant recovery in barrier function, whereas pseudo-acylceramide with ester-linked oleic acid and other different acyl properties, ordinary pseudo-ceramides with several alkyl properties, and pseudo-acylceramide containing amide-linked odd numbered fatty acid with ester-linked linoleic acid had no significant recovery effect on TEWL. Due to the difficulty of producing biological cleavage of ether-linked linoleic acid, evidence showing a recovery effect with the pseudo-ceramide containing etherlinked linoleic acid is very important in ruling out the possibility that linoleic acid released through enzymatic or nonenzymatic cleavage from the pseudo-acylceramide could have produced the recovery effect (16) . This possibility was also excluded by our experiments using pseudo-acylceramide with radiolabeled linoleic acid; all the radioactivity of ['4C]BRS-001 was confined to the stratum corneum without releasing [ the amide-linked even-numbered fatty acid in BRS-001) which is presumed to have a similar likelihood of being degraded by hydrolytic processes, was not effective in recovering TEWL. The above findings indicate that the acylceramide with esterlinked linoleic acid plays an important role in cutaneous barrier function.
In EFAD animals, linoleic acid is an essential requirement for maintaining the epidermal barrier function. However, the recent discovery of linoleate-rich acylceramides (17) has suggested mechanisms whereby the nature of the ester-linked linoleic acid is associated directly with the formation of the intercellular lamellae and the stabilization of an orderly and impermeable physical structure in the stratum corneum (3) . Thus, the beneficial effects of topically applied linoleic acid on EFAD have been ascribed to their conversion to linoleaterich acylceramides rather than to the cyclooxygenase or lipoxygenase products ( 18 ). Columbinic acid also corrects the barrier-deficiency state despite the failure of the cyclooxygenase or lipoxygenase products to normalize the epidermal water loss (19, 20) . This also provides evidence that the nature of the ester-linked fatty acid in the acylceramides regulates the permeability barrier, although the recovery effect of the acylceramide with ester-linked columbinic acid remains to be clarified. The evidence for the structural significance of acylceramide with linoleic acid in the barrier function is also supported by our observation that, whereas the pseudoacylceramides with dioxsoran-adduct acid (BRS-025, 035) 94 Imokawa et al. 
